MARKET WRAP: JSE firmer on positive Covid-19 vaccine news
Volatile Sun International share was among the biggest gainers after it agreed to sell its majority stake in Latin American operation Sun Dreams
The JSE gained for the first time in four days on Friday as optimism about a viable Covid-19 vaccine being produced in the next few months lifted sentiment, with Sun International among the best performers on the day.
Pfizer Inc and BioNTech said the Covid-19 vaccine they are jointly developing is on track to be submitted for regulatory review as early as October, news that helped lift sentiment which has been buffeted by concern about the effect of the pandemic on economic activity. Last month the companies clinched a $2bn deal to supply an initial 100-million doses of the vaccine to the US. Meanwhile, Russia is set to start international clinical trials of its Sputnik V vaccine...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.